View: |
Part 1: Document Description
|
Citation |
|
---|---|
Title: |
Replication Data for "Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model" |
Identification Number: |
doi:10.13130/RD_UNIMI/I4YV97 |
Distributor: |
UNIMI Dataverse |
Date of Distribution: |
2021-01-22 |
Version: |
1 |
Bibliographic Citation: |
Mazzucchelli, Serena, 2021, "Replication Data for "Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model"", https://doi.org/10.13130/RD_UNIMI/I4YV97, UNIMI Dataverse, V1, UNF:6:xfaXC5orDOjsTMNER2uGAQ== [fileUNF] |
Citation |
|
Title: |
Replication Data for "Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model" |
Identification Number: |
doi:10.13130/RD_UNIMI/I4YV97 |
Authoring Entity: |
Mazzucchelli, Serena (University of Milan) |
Distributor: |
UNIMI Dataverse |
Access Authority: |
Mazzucchelli, Serena |
Depositor: |
Mazzucchelli, Serena |
Date of Deposit: |
2020-02-27 |
Holdings Information: |
https://doi.org/10.13130/RD_UNIMI/I4YV97 |
Study Scope |
|
Keywords: |
Medicine, Health and Life Sciences, Nanomedicine |
Abstract: |
This datatset contains raw data obtained in HFnDOX+tZ project and published in Andreata et al. Sci.reports 2020 |
Methodology and Processing |
|
Sources Statement |
|
Data Access |
|
Other Study Description Materials |
|
Related Publications |
|
Citation |
|
Identification Number: |
https://doi.org/10.1038/s41598-020-68205-w |
Bibliographic Citation: |
Andreata, F., Bonizzi, A., Sevieri, M. et al. Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model. Sci Rep 10, 11425 (2020). |
File Description--f4922 |
|
File: Dataverse_ Sci_rep_2020_alpha SMA.tab |
|
|
|
Notes: |
UNF:6:BuXmM8Q0f7ICNZjXIKIacg== |
File Description--f4911 |
|
File: Dataverse_ Sci_rep_2020_CD31.tab |
|
|
|
Notes: |
UNF:6:ddtekNq074LHEZN3ul5leg== |
File Description--f4912 |
|
File: Dataverse_ Sci_rep_2020_Granzyme quantification.tab |
|
|
|
Notes: |
UNF:6:LDh4VsXU8ptRv/ywDTgcig== |
File Description--f4905 |
|
File: Dataverse_ Sci_rep_2020_mitochondria area.tab |
|
|
|
Notes: |
UNF:6:OLdgazkM7mFJ0UyL+8T2ww== |
File Description--f4908 |
|
File: Dataverse_ Sci_rep_2020_mitochondria cristae area.tab |
|
|
|
Notes: |
UNF:6:jj+DNih8QKGa4JpNKLKAKA== |
File Description--f4906 |
|
File: Dataverse_ Sci_rep_2020_mitochondria number.tab |
|
|
|
Notes: |
UNF:6:2ORjaL86Xusak3R2DQnWRg== |
File Description--f4920 |
|
File: Dataverse_ Sci_rep_2020_TILs.tab |
|
|
|
Notes: |
UNF:6:1iAP2zm7Km+gmutbiNmYUw== |
File Description--f4917 |
|
File: Dataverse_ Sci_rep_2020_Toxicity assays.tab |
|
|
|
Notes: |
UNF:6:iXZxt5TLrQ3rhpcyMrFk7A== |
File Description--f4913 |
|
File: Dataverse_ Sci_rep_2020_Tumor growth.tab |
|
|
|
Notes: |
UNF:6:+VkR7tzCczAGe1twZVoVKg== |
File Description--f4907 |
|
File: Dataverse_ Sci_rep_2020_Tumor size day 24.tab |
|
|
|
Notes: |
UNF:6:7QJkU2sr2U5AMB3Pl+pJ6A== |
File Description--f4909 |
|
File: Dataverse_ Sci_rep_2020_Tunel assay.tab |
|
|
|
Notes: |
UNF:6:3BDULdnwZtYVFbGZXQG7Hw== |
File Description--f4921 |
|
File: Dataverse_ Sci_rep_2020_TZ penetration.tab |
|
|
|
Notes: |
UNF:6:r5N9H5tYRn8eRq+6SJV2Yg== |
File Description--f4910 |
|
File: Dataverse_ Sci_rep_2020_TZ quantification.tab |
|
|
|
Notes: |
UNF:6:4v7kmCBYAzg6tyVzL5eIyg== |
Label: |
Dataverse_ Sci_rep_2020_DOX and DOXol quantification.xls |
Text: |
Figure S2 |
Notes: |
application/vnd.ms-excel |